After nearly quadrupling over the past month, it's time to get out of Moderna (MRNA) stock, a Citi analyst said Wednesday as he downgraded shares to a sell rating.
Read the original report for the complete account of this story.
POLARIS INSIGHTS
After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst
